X

Trial Profile

Multi-Center, Open-Label, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Jul 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mogamulizumab (Primary)
Indications Adult T-cell leukaemia-lymphoma
Focus Registrational; Therapeutic Use
Sponsors Kyowa Hakko Kirin; Kyowa Kirin

Most Recent Events

16 Dec 2019 Results assessing population pharmacikinetic modeling by using data from six studies including this study published in the Journal of Clinical Pharmacology.
16 May 2018 Status changed from active, no longer recruiting to completed.
20 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com